These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 348305)

  • 1. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
    Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
    Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
    Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
    Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 12. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
    Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG; Murray N; Warde P
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
    Eagan RT; Maurer LH; Forcier RJ; Tulloh M
    Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in bronchogenic carcinoma.
    Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
    Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.